Patent Lens is a worldwide, open-access, free full-text patent informatics
resource. It serves as the cyberinfrastructure platform for the Initiative for
Open Innovation. Why are we doing this?
- Search and retrieve the full-text of more than 9 million patent documents
from US, Europe, Australia and WIPO, their status and counterparts up to 70
countries.
- We will soon be releasing the latest version of our beta search interface.
Thank you to all those who provided feedback on the previous version.
- Landscapes are 'interpretation maps' that integrate volumes of specialized
patent data around particular topics into a more navigable form.
Transparency of the worldwide patent system must be an international public
good; This is your resource, and we need your help to
keep it open and free.
|
|
Patent Lens New Features
|
- Search technology now independent of language; Chinese (中文) PCTs now fully
text-searchable.
- Search for lapsed, abandoned or expired US Patents.
- Visualize Patent Families with new graphical trees as PDFs.
- Patent Landscapes on
Influenza Genes,
Rice Genome and
Adjuvants
now online.
-
Protein & DNA Sequence searching of over 80
million sequences from worldwide patent collections.
|
|
Patent Lens in the News
|
Intellectual Property Watch, Kenya October 19, 2009
CIO, Australia October 6, 2009
Business Standard, India August 5, 2009
Navigation of this complex [patent] landscape is set to become much easier and more promising.
The Economist, US July 16, 2009
Several new initiatives have been announced that will help cure the diseases of the poor world. Among them is the new Initiative for Open Innovation.
|
|
Nature Biotechnology editorial, May 2006 (info)
The ability to interpret and filter intellectual property (IP) has never
been more important...CAMBIA's Patent Lens is a giant leap in the right
direction"
|
|
Red Herring Cover-story and editorial, April 17,
2006 (info)
Patent transparency is the lifeblood of the new open source"
-Influential IT mag features CAMBIA's role in changing the face of life
sciences innovation.
(info)
|
|
» More News/Press items...
|
|
|
There are no comments.